Study of Pembrolizumab and M032 (NSC 733972)

NCT05084430 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma Multiforme
Anaplastic Astrocytoma
Gliosarcoma

Interventions

DRUG: M032
DRUG: Pembrolizumab

Sponsor

University of Alabama at Birmingham